Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Colorectal Cancer, Targeted Therapy

Takayuki Yoshino

MD, PhD

🏢National Cancer Center Hospital East🌐Japan

Director, Department of Gastroenterology and Gastrointestinal Oncology

75
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Takayuki Yoshino leads international colorectal cancer trials from Japan and co-chaired the BEACON CRC study. He has pioneered biomarker-driven strategies for metastatic CRC including HER2 and BRAF subsets, and the FRESCO-2 global fruquintinib trial. He serves on major international guideline committees.

Share:

🧪Research Fields 研究领域

metastatic CRC
HER2 CRC
fruquintinib
trifluridine tipiracil
Asian CRC trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Takayuki Yoshino 的研究动态

Follow Takayuki Yoshino's research updates

留下邮箱,当我们发布与 Takayuki Yoshino(National Cancer Center Hospital East)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment